NPPB and pulmonary arterial hypertension: However, separate miRNA signatures to identify WSPH subgroups of PH did outperform NT-proBNP, specifically in classifying patients with WSPH Group 1: PAH and WSPH Group 4.1: CTEPH from a mixed PH population of patients with all causes of PH.